Delivery Order SPE2DR25D1017-SPE2DR26F8ZCL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order valued at $1,788.24 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL). The contract, which represents a non-competitive set-aside delivery, is scheduled for completion by October 31, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a $11,761.50 firm fixed price delivery order by the Defense Logistics Agency (DLA) on November 4, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of November 5, 2025, with performance to be conducted at the company's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transactional award under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $3,832.33 to supply Trulicity 0.75 mg/0.5 ml pens. This competitive, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and represents a continuation of the company's pharmaceutical supply services supporting federal military and veteran healthcare systems. The award carries no set-aside...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $3,176.08. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, awarded on September 24, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,109.08 by the Defense Logistics Agency on September 25, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 26, 2025, and performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger pharmaceutical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $9,723.60 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Trulicity 3 mg/0.5 ml pens. The delivery order was awarded on November 1, 2023 under the indefinite delivery contract with no set-aside designation used. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 2, 2023. As a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 mL pens valued at $1,334.04. The contract employs firm fixed pricing with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025, without set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZCLDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,907.40 by the Defense Logistics Agency on November 5, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 6, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As the primary pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies critical medications and medical supplies across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems worldwide. The company's extensive portfolio of federal contract awards demonstrates consistent capability to fulfill complex medical supply requirements through open competition, with this delivery order representing a routine transaction within the broader context of the company's substantial pharmaceutical supply relationship with the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/5/25 |